These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 1378157)

  • 1. Effects of carvedilol on atrial natriuretic peptide, catecholamines, and hemodynamics in hypertension at rest and during exercise.
    Omvik P; Lund-Johansen P; Myking O
    J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S90-6. PubMed ID: 1378157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carvedilol in hypertension: effects on hemodynamics and 24-hour blood pressure.
    Lund-Johansen P; Omvik P; Nordrehaug JE; White W
    J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S27-34. PubMed ID: 1378146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resting and postexercise hemodynamic effects of carvedilol, a beta-adrenergic blocker and precapillary vasodilator in hypertensive patients.
    Leonetti G; Sampieri L; Cuspidi C; Boselli L; Terzoli L; Rupoli L; Zanchetti A
    J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S94-6. PubMed ID: 2454377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute haemodynamic effects of carvedilol in essential hypertension at rest and during exercise.
    Omvik P; Lund-Johansen P
    Eur Heart J; 1991 Jun; 12(6):736-40. PubMed ID: 1860471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentiation of natriuretic peptide action by the beta-adrenergic blocker carvedilol in hypertensive rats: a new antihypertensive mechanism.
    Yoshimoto T; Naruse M; Tanabe A; Naruse K; Seki T; Imaki T; Muraki T; Matsuda Y; Demura H
    Endocrinology; 1998 Jan; 139(1):81-8. PubMed ID: 9421401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term hemodynamic effects at rest and during exercise of newer antihypertensive agents and salt restriction in essential hypertension: review of epanolol, doxazosin, amlodipine, felodipine, diltiazem, lisinopril, dilevalol, carvedilol, and ketanserin.
    Omvik P; Lund-Johansen P
    Cardiovasc Drugs Ther; 1993 Apr; 7(2):193-206. PubMed ID: 8395198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic haemodynamic effects of carvedilol in essential hypertension at rest and during exercise.
    Lund-Johansen P; Omvik P
    Eur Heart J; 1992 Feb; 13(2):281-6. PubMed ID: 1555629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic effects of carvedilol after acute oral administration in hypertensive and normal subjects.
    Cournot A; Lim C; Duchier J; Safar M
    J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S35-9. PubMed ID: 1378147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of carvedilol on common carotid arterial flow, peripheral hemodynamics, and hemorheologic variables in hypertension.
    Nagakawa Y; Akedo Y; Kaku S; Orimo H
    Eur J Clin Pharmacol; 1990; 38 Suppl 2():S115-9. PubMed ID: 1974500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the hemodynamic effects of metoprolol and carvedilol in hypertensive patients.
    Weber K; Bohmeke T; van der Does R; Taylor SH
    Cardiovasc Drugs Ther; 1996 May; 10(2):113-7. PubMed ID: 8842502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic differences between metoprolol and carvedilol in hypertensive patients.
    Weber K; Bohmeke T; van der Does R; Taylor SH
    Am J Hypertens; 1998 May; 11(5):614-7. PubMed ID: 9633801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute hemodynamic effects of carvedilol in comparison with propranolol in patients with coronary heart disease.
    Wendt T
    Clin Investig; 1992; 70 Suppl 1():S93-7. PubMed ID: 1350491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of carvedilol and metoprolol on blood pressure, blood flow, and vascular resistance.
    Morgan T; Snowden R; Butcher L
    J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S124-9. PubMed ID: 2454358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute haemodynamic effects of carvedilol (BM 14190), a new combined beta-adrenoceptor blocker and precapillary vasodilating agent, in hypertensive patients.
    Eggertsen R; Andrén L; Sivertsson R; Hansson L
    Eur J Clin Pharmacol; 1984; 27(1):19-22. PubMed ID: 6149128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term hemodynamic effects of antihypertensive treatment.
    Lund-Johansen P; Omvik P; Nordrehaug JE
    Clin Investig; 1992; 70 Suppl 1():S58-64. PubMed ID: 1350486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute hemodynamic effects of the vasodilating and beta-blocking agent carvedilol in comparison to propranolol.
    Wendt T; van der Does R; Schräder R; Landgraf H; Kober G
    J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S147-50. PubMed ID: 2454362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of carvedilol on ambulatory blood pressure, renal hemodynamics, and cardiac function in essential hypertension.
    Dupont AG; Van der Niepen P; Taeymans Y; Ingels M; Piepsz A; Bossuyt AM; Block P; Six RO; Jonckheer MH; Vanhaelst L
    J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S130-6. PubMed ID: 2454359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute and long-term hemodynamic effects of carvedilol, a combined beta-adrenoceptor blocking and precapillary vasodilating agent, in hypertensive patients.
    Eggertsen R; Sivertsson R; Andrén L; Hansson L
    J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S97-100. PubMed ID: 2454378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodynamic profile of carvedilol.
    Hombach V; Kochs M; Höher M; Eggeling T; Haerer W; Wieshammer S; Schmidt A
    Eur J Clin Pharmacol; 1990; 38 Suppl 2():S101-3. PubMed ID: 1974496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carvedilol in hypertension treatment.
    Stafylas PC; Sarafidis PA
    Vasc Health Risk Manag; 2008; 4(1):23-30. PubMed ID: 18629377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.